Learn About Telangiectasia

What is the definition of Telangiectasia?

Telangiectasias are small, widened blood vessels on the skin. They are usually harmless, but may be associated with several diseases.

What are the alternative names for Telangiectasia?

Vascular ectasias; Spider angioma

What are the causes of Telangiectasia?

Telangiectasias may develop anywhere within the body. But they are most easily seen on the skin, mucous membranes, and whites of the eyes. Usually, they do not cause symptoms. Some telangiectasias bleed and cause significant problems. Telangiectasias may also occur in the brain or intestines and cause major problems from bleeding.

Causes may include:

  • Rosacea (skin problem that causes the face to turn red)
  • Aging
  • Problem with genes
  • Pregnancy
  • Sun exposure
  • Varicose veins
  • Overuse of steroid creams
  • Trauma to the area

Diseases associated with this condition include:

  • Ataxia-telangiectasia (disease that affects the skin, balance, coordination, and other areas of the body)
  • Bloom syndrome (inherited disease that causes short stature, skin sensitivity to ultraviolet rays of the sun, and redness of the face)
  • Cutis marmorata telangiectatica congenita (skin disease causing patches of redness)
  • Hereditary hemorrhagic telangiectasia (Osler-Weber-Rendu syndrome)
  • Klippel-Trenaunay-Weber syndrome (disease that causes port-wine stain, varicose veins, and soft tissue problems)
  • Nevus flammeus such as port-wine stain
  • Rosacea (skin condition that causes redness of the face)
  • Sturge-Weber disease (disease that involves port-wine stain and nervous system problems)
  • Xeroderma pigmentosum (disease in which the skin as well as the tissue covering the eye are extremely sensitive to ultraviolet light)
  • Lupus (immune system disease)
  • CREST syndrome (a type of scleroderma that involves the buildup of scar-like tissue in the skin and elsewhere in the body and damages the cells that line the walls of small arteries)
When should I contact a medical professional for Telangiectasia?

Call your health care provider if you notice enlarged vessels in the skin, mucous membranes, or eyes.

What should I expect during a doctor appointment?

Your provider will perform a physical exam and ask about your symptoms, including:

  • Where are the blood vessels located?
  • Do they bleed easily and without reason?
  • What other symptoms are present?

Tests may be needed to diagnose or rule out a medical condition. Tests may include:

  • Blood tests
  • CT scans
  • Liver function studies
  • MRI scans
  • X-rays

Sclerotherapy is the treatment for telangiectasias on the legs. In this procedure, a saline (salt) solution or other chemical is injected directly into the spider veins on the legs. Laser treatment is typically used to treat telangiectasias of the face.

Who are the top Telangiectasia Local Doctors?
Experienced in Telangiectasia
Experienced in Telangiectasia
1520 San Pablo St, 
Los Angeles, CA 
 (2.3 mi)
Languages Spoken:
English, American Sign Language, Sign Language
Accepting New Patients

Ashley Wysong is a Dermatologist in Los Angeles, California. Dr. Wysong and is rated as an Experienced provider by MediFind in the treatment of Telangiectasia. Her top areas of expertise are Basal Cell Skin Cancer, Squamous Cell Skin Carcinoma, Melanoma, and Keloids. Dr. Wysong is currently accepting new patients.

Experienced in Telangiectasia
Family Medicine
Experienced in Telangiectasia
Family Medicine
450 Bauchet St., Room E873, 
Los Angeles, CA 
 (0.7 mi)
Languages Spoken:
English

Min Kim is a Family Medicine provider in Los Angeles, California. Dr. Kim and is rated as an Experienced provider by MediFind in the treatment of Telangiectasia. Her top areas of expertise are Subvalvular Aortic Stenosis, Hereditary Hemorrhagic Telangiectasia, and Telangiectasia.

 
 
 
 
Learn about our expert tiers
Learn More
Experienced in Telangiectasia
Experienced in Telangiectasia

USC Care Medical Group Inc

830 S Flower St, Suite B100, 
Los Angeles, CA 
 (1.2 mi)
Languages Spoken:
English

Nada Elbuluk is a Dermatologist in Los Angeles, California. Dr. Elbuluk and is rated as an Experienced provider by MediFind in the treatment of Telangiectasia. Her top areas of expertise are Hypomelanotic Disorder, Vitiligo, Melasma, and Acne.

What are the latest Telangiectasia Clinical Trials?
A Randomized Phase 2 Study of ATR Inhibition in Advanced PD-(L)1-Refractory Merkel Cell Carcinoma: The MATRiX Trial

Summary: This phase II trial compares tuvusertib in combination with avelumab to tuvusertib alone to determine whether the combination therapy will lengthen the time before the cancer starts getting worse in patients with Merkel cell cancer that has not responded to previous treatment (refractory). Tuvusertib is a drug that inhibits an enzyme called ataxia telangiectasia and Rad3 related (ATR) kinase, whic...

Match to trials
Find the right clinical trials for you in under a minute
Get started
Efficiency of Determining the Clinical Class of Chronic Venous Disorders by Artificial Intelligence (IVENUS App)

Summary: Purpose: To evaluate the sensitivity and specificity of the method for determining the clinical class of chronic venous diseases using the Ivenus application (within C0-C2 according to CEAP). Materials and methods: Patients who applied to several phlebology clinics for an initial consultation are consistently included in a multicenter prospective study. At the appointment, a doctor with at least 5...

Who are the sources who wrote this article ?

Published Date: June 07, 2023
Published By: Elika Hoss, MD, Assistant Professor of Dermatology, Mayo Clinic, Scottsdale, AZ. Also reviewed by David C. Dugdale, MD, Medical Director, Brenda Conaway, Editorial Director, and the A.D.A.M. Editorial team.

What are the references for this article ?

Kelly R, Baker C. Other vascular disorders. In: Bolognia JL, Schaffer JV, Cerroni L, eds. Dermatology. 4th ed. Philadelphia, PA: Elsevier; 2018:chap 106.

Patterson JW. Vascular tumors. In: Patterson JW, ed. Weedon's Skin Pathology. 5th ed. Philadelphia, PA: Elsevier Limited; 2021:chap 39.